News and Events

  • Overworked staff? The T-TAS® 01 platelet function analyzer can lighten the burden

    Posted: October 18, 2022

    It’s Not Just Support. It’s Solutions. T-TAS® 01 PL Assay: One test, one result, one total answer for platelet function Help address staffing and budgetary challenges with a frontline test for overall total platelet function Single assay with easy-to-interpret test result provides simple and comprehensive platelet reactivity status Consolidate testing from multiple platforms, for better…

    Read More

  • Go further than FEV1 and FVC – Mechanistic Biomarkers for Lung Disease

    Posted: October 11, 2022

    It’s Not Just Support. It’s Solutions. A Case for Letting Endotype Lead the Way in Drug Development…   Neutrophilic      VS      Eosinophilic The molecular mechanisms that drive chronic lung disease are heterogenetic. To evolve past a “one drug fits all approach”, toward a more individualized and precision approach, pharmaceutical companies are focusing…

    Read More

  • Factor XIII Assays to Fit Your Needs

    Posted: September 30, 2022

    t’s Not Just Support. It’s Solutions. Factor XIII Activity Assays – The Right Fit for your Needs Manual and automated solutions for measuring FXIII Activity Technofluor® Factor XIII Fully automated on the Ceveron s100 for the determination of FXIII activity levels. Minimal hands-on time Data in under 30 minutes Single calibration per lot No need…

    Read More

  • Endotyping for Clinical Trial Success with COPD, bronchiectasis, asthma

    Posted: September 29, 2022

    It’s Not Just Support. It’s Solutions. Endpoints for clinical trials in lung disease could be better… FEV1 and FVC are relatively blunt tools for getting a complete picture of a disease state – they do not provide information on the pulmonary microenvironment. Inflammation is a hallmark of chronic lung diseases and an important piece of…

    Read More

  • Measure fibrosis in a more meaningful way using TOTAL collagen assays

    Posted: September 28, 2022

    It’s Not Just Support. It’s Solutions. Let DiaPharma introduce you to a new partner in fibrosis research, QuickZyme Biosciences DiaPharma is excited to announce that we now offer QuickZyme products. QuickZyme knows, “Matrix Matters”. Collagens are a main component of the extracellular matrix and are the most abundant proteins in the body. Collagens play important…

    Read More

  • Tools for Sickle Cell Disease Research

    Posted: September 22, 2022

    It’s Not Just Support. It’s Solutions. Tools for Sickle Cell Disease Research September is National Sickle Cell Awareness Month. From Anti-Hemoglobin S antibodies, coagulation kits, and biomarker assays, to exciting new instrumentation for clotting analysis, DiaPharma has what matters covered for impactful Sickle Cell research. Research projects like gene therapy require many decisions, including investigating…

    Read More

  • Time to include Human TSP2 in your next NASH study?

    Posted: September 14, 2022

    It’s Not Just Support. It’s Solutions.   Time to include Thrombospondin-2 in your next NASH study… Thrombospondin-2 has been identified by transcriptomics as an emerging NASH biomarker. Protein analysis shows that it has promise for use in studying NAFLD, NASH, metabolic disease, and diabetes. This Human TSP2 ELISA kit, from ImmunoDiagnostics, is proven reliable for…

    Read More

  • What’s New at DiaPharma?

    Posted: August 15, 2022

    It’s Not Just Support. It’s Solutions. Meet Genesis Cautivar West Territory Manager Genesis Cautivar joined DiaPharma in July 2022. He is a native of Vancouver, British Columbia, Canada and currently resides in the Dallas-Fort Worth, Texas Metroplex. He received his B.S. in Medical Technology from Walla Walla University (WA). He has many years of experience…

    Read More

  • Exploratory Biomarkers for Acute and Chronic Kidney Injury Studies

    Posted: June 28, 2022

    It’s Not Just Support. It’s Solutions. Spotlight on Acute and Chronic Kidney Injury Enhanced assays with improved sensitivity and specificity to assist in kidney disease studies L-FABP ● NGAL ● Osteopontin ● alpha-GST ● Cystatin C ● RBP4 ● Anti-EHEC There are large gaps in the information that standard kidney markers, like serum creatinine, can…

    Read More

  • News from the front lines at SOT 2022: Checkpoint Inhibitor Liver Toxicity

    Posted: June 7, 2022

    It’s Not Just Support. It’s Solutions.   Spotlight on Liver Toxicity: Immune-mediated Liver Injury Caused by Checkpoint Inhibitors (ILICI) One thing that jumped out at the Society of Toxicology (SOT) meeting this past March was a new phase of liver toxicology research focused on therapies that have a direct effect on immune function, specifically, hepatotoxicity…

    Read More

  • Measure True Beta Cell Dysfunction with TECO Intact Proinsulin

    Posted: June 6, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro! TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only intact proinsulin. Proinsulin is synthesized in pancreatic β-cells and secreted as insulin. Insulin resistance (IR) or hyperglycemia causes increased secretion and finally secretion…

    Read More

  • T-TAS®01 – The Leading Edge in Platelet Thrombus Formation Assessment

    Posted: June 1, 2022

    It’s Not Just Support. It’s Solutions. Innovative Total Platelet Function Analysis using Whole Blood Global evaluation of overall hemostatic ability using physiologic, flow conditions Exclusively from DiaPharma. Advantages of T-TAS® 01 PL Assay Ease of Interpretation A numeric cut-off easily identifies those with primary hemostasis disorders, assisting with more timely determination of appropriate treatment strategy…

    Read More

  • Respiratory Research Solutions from DiaPharma

    Posted: May 16, 2022

    It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source for ProAxsis products   Reach out to DiaPharma’s Olivia Stricker, who will be at American Thoracic Society (ATS) 2022 in San Francisco, May 13 – 16. Elevate your clinical research data by measuring active proteases Targets: Drug development evaluating new protease inhibitors or anti-inflammatory…

    Read More

  • Comprehensive Solutions for Anticoagulation Research

    Posted: May 9, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. Thrombin Generation Testing Manual or automated options for studying potential new anticoagulants Technothrombin® TGA*…

    Read More

  • What’s New at DiaPharma?

    Posted: April 28, 2022

    It’s Not Just Support. It’s Solutions. Meet Ryan McCaw Midwest Territory Manager Ryan joined DiaPharma in January of 2022. He obtained his BS in Medicine from the University of Iowa where he also completed the Medical Technology program. He was certified as a Medical Technologist with the ASCP and started his career in medical research…

    Read More

  • Emerging Biomarkers in Alcoholic Liver Disease

    Posted: April 14, 2022

    It’s Not Just Support. It’s Solutions. Non-Invasive Biomarkers for Alcoholic Liver Disease Studies Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcoholic Liver Disease (ALD) and Alcoholic Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into: Disease severity and progression in ALD and…

    Read More

  • Thrombin Generation Assay for Cancer Associated Thrombosis Research

    Posted: April 12, 2022

    It’s Not Just Support. It’s Solutions. Technothrombin® and Ceveron® TGA Thrombin Generation Testing for Cancer-Associated Thrombosis Research Thrombosis is a common complication for individuals with cancer. Risk varies by malignancy type, treatment approaches, and individual risk factors. Thrombin generation assays (TGA) provide a global context of thrombosis. When you want to measure thrombin generation in…

    Read More

  • Assays for your Gene Therapy Research in Rare Diseases

    Posted: March 3, 2022

    It’s Not Just Support. It’s Solutions. Explore Assays for Gene Therapy and Cell Therapy Research in Rare Diseases   HEMOPHILIA A & B Chromogenic FVIII – Coamatic® FVIII, Coatest® SP/SP4 FVIII Sensitive and reproducible, featuring bovine factor reagents Chromogenic FIX – ROX FIX* Bringing chromogenic FIX testing into the next era with unsurpassed sensitivity SICKLE…

    Read More

  • Non-Invasive, Non-Destructive Ecotoxicology Assays

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. Environmental Impact Matters.   PERFORM ENDOCRINE DISRUPTOR STUDIES WITHOUT KILLING THE FISH NON-INVASIVE, EASY TO USE, ACCURATE ECOTOXICOLOGY ELISAs Use TECO® Mucus Collection Swabs and test kits to test fish: follow individuals and populations over time endocrine disruption – vitellogenin ELISA liver damage – hyaluraonic acid ELISA stress –…

    Read More

  • Go with the Pro – Intact Proinsulin for your Diabetes Research

    Posted: February 23, 2022

    It’s Not Just Support. It’s Solutions. When it comes to measuring pancreatic Beta cell function, go with the Pro!   TECO® Intact Proinsulin ELISA Save time and guess work by selectively measuring only active proinsulin. Only 1% to 3% of proinsulin is secreted intact. However, because proinsulin has a longer half-life than insulin, circulating proinsulin…

    Read More